FDA — authorised 14 August 2023
- Application: BLA761345
- Marketing authorisation holder: PFIZER INC
- Local brand name: ELREXFIO
- Indication: SOLUTION — INJECTION
- Status: approved
🇺🇸 Elrexfio in United States
FDA authorised Elrexfio on 14 August 2023
Marketing authorisations
FDA
- Status: approved
Elrexfio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Elrexfio approved in United States?
Yes. FDA authorised it on 14 August 2023; FDA has authorised it.
Who is the marketing authorisation holder for Elrexfio in United States?
PFIZER INC holds the US marketing authorisation.